It may be the key to Cynarine’s prevention and treatment of NAFLD that PI3K-Akt signaling pathway, cell cycle and MAPK signaling pathway and other potential signal pathways were regulated to interfere with inflammation and immunity, metabolic homeostasis, lipotoxicity, liver cell death and other mechanisms. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.